Insight

Yan Leyfman

Jun 21, 2025, 15:40

Yan Leyfman Presented Research on Cancer Immunotherapy at 2025 Frontiers in Immunotherapy Conference

Yan Leyfman, Co-founder and Executive Director of MedNews Week, shared a post on LinkedIn:

“Honored to have been invited to present our research from Icahn School of Medicine at Mount Sinai and MedNews Week at the 2025 The New York Academy of Sciences: Frontiers in Immunotherapy Conference!

It was an inspiring experience to learn from the trailblazers of immuno-oncology and connect with giants in the field. A special highlight: meeting Keynote Speakers and Immunotherapy Legends Dr. Antoni Ribas (UCLA) and Dr. Stanley Riddell (FRED HUTCHINSON CANCER RESEARCH).

Their standing-room-only talks were nothing short of masterclasses, and I’m incredibly grateful for the time they took to speak with me – grateful for your mentorship and advice.

Here’s to pushing the boundaries of science, together!”

Immunotherapy Conference

More posts featuring Yan Leyfman on OncoDaily.

Antoni Ribas cancer FRED HUTCHINSON CANCER RESEARCH Icahn School of Medicine Immunotherapy Conference MedNews Week New York Academy of Sciences OncoDaily Oncology Stanley Riddell UCLA Yan Leyfman

Cancer in Dogs: Common Types, Symptoms, Diagnosis, and Treatment

Cardio-Oncology in Focus: How Chemotherapy Can Harm Heart Health

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself

Cervical Cancer Screening: Who Needs a Pap Smear or HPV Test and When?